Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia

Risnik, D; Colado, A; Podaza, E; Almejun, MB; Elias, EE; Bezares, RF; Fernandez-Grecco, H; Seija, N; Oppezzo, P; Borge, M; Gamberale, R; Giordano, M

Risnik, D (corresponding author), CONICET Acad Nacl Med ANM, Inst Med Expt IMEX, Lab Inmunol Oncol, Pacheco Melo 3081, RA-1425 Buenos Aires, DF, Argentina.

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020; 69 (5): 813

Abstract

Despite significant therapeutic improvements chronic lymphocytic leukemia (CLL) remains an incurable disease and there is a persistent pursuit of new ......

Full Text Link